2021-01-08,SemiLEDs Reports First Quarter Fiscal Year 2021 Financial Results
2021-01-06,"SemiLEDs to Announce Fiscal First Quarter 2021 Financial Results on Friday, January 8, 2021"
2020-12-23,Insider Sells Tyme Technologies Shares
2020-12-15,We're Keeping An Eye On Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate
2020-12-09,TYME Announces SM-88 Abstract Selected for Presentation at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium
2020-11-30,TYME Builds Leadership Team with Announcement of New CEO
2020-11-27,"Is Tyme Technologies, Inc. (TYME) Going to Burn These Hedge Funds?"
2020-11-12,TYME Provides Business Update and Announces Second Quarter Fiscal 2021 Financial and Operating Results
2020-10-13,"Tyme Technologies to Present at Jefferies Virtual Global Healthcare Conference on November 17-19, 2020"
2020-09-16,"Is Tyme Technologies, Inc.'s (NASDAQ:TYME) Shareholder Ownership Skewed Towards Insiders?"
2020-09-15,"TYMEs Phase II Prostate Cancer Study Evaluating SM-88 in Patients with Non-Metastatic Recurrent Prostate Cancer Published in the Journal, Investigational New Drugs"
2020-09-14,"Tyme Technologies to Present at BioNJs 10th Annual BioPartnering Conference on October 6, 2020"
2020-09-09,"Tyme Technologies to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22, 2020"
2020-09-02,"Tyme Technologies to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15, 2020"
2020-08-26,TYMEs Oncology Research Reveals Potential New Oral Therapy TYME-19 in the Fight Against COVID-19
2020-08-21,Tyme Technologies to Present at the 2020 CHINABIO® Partnering Forum
2020-08-19,"TYME Announces Appointment of John Rothman, Ph.D. to Executive Vice President, Product Development"
2020-08-18,Insider Sells Tyme Technologies's Shares
2020-08-11,TYME Announces Outcome of Interim Futility Review for HopES Sarcoma Phase II Study
2020-08-03,Why Tyme Technologies's Stock Is Trading Higher Today
2020-08-03,TYME Announces Orphan Drug Designation for SM-88 as Potential Treatment for Patients with Pancreatic Cancer
2020-07-21,"Tyme Technologies to Present at Canaccord 40th Annual Growth Conference on August 13, 2020"
2020-07-14,Insider Sells Tyme Technologies' Stock
2020-07-13,TYME Provides Business Update and Announces Preliminary First Quarter Fiscal 2021 Financial and Operating Results
2020-07-10,Tyme Technologies Announces Virtual 2020 Annual Meeting of Stockholders
2020-07-07,Insider Sells Tyme Technologies Shares
2020-06-23,TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020
2020-06-22,TYME Presents New Preclinical Data Supporting SM-88 Mechanism of Action at AACR 2020
2020-06-04,"Hedge Funds Are Nibbling On Tyme Technologies, Inc. (TYME)"
2020-05-28,TYME Announces Abstracts Selected for Publication at the 2020 American Society of Clinical Oncology Annual Meeting
2020-05-27,"Tyme Technologies to Present at BIO Digital from June 8-12, 2020"
2020-05-20,TYME Announces Fourth Quarter and Fiscal Year 2020 Financial and Operating Results
2020-05-20,"Tyme Technologies, Inc. to Host Earnings Call"
2020-05-19,"Tyme Technologies to Present at Jefferies Virtual Healthcare Conference on June 3, 2020"
2020-05-15,"TYME Announces Abstracts Selected for Presentation at the American Association for Cancer Research, AACR 2020"
2020-05-12,"Tyme Technologies to Webcast Conference Call of Fourth Quarter and Fiscal Year 2020 Financial and Operating Results on May 20, 2020"
2020-05-06,"How Tyme Technologies, Inc. (NASDAQ:TYME) Can Impact Your Portfolio Volatility"
2020-04-06,Tyme Technologies to Present at the 2020 Cross-Border Healthcare Webinar Series
2020-02-05,TYME Announces Third Quarter Fiscal 2020 Financial and Operating Results
2020-01-27,Health Economic Research Study Demonstrates Increased Use of New Medicines in the Treatment of Patients with Pancreatic Cancer Reduces Total Cost of Care
2020-01-16,TYME and The Joseph Ahmed Foundation Announce First Patient Dosed in Phase II (HopES) Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with High-Risk Sarcomas
2020-01-09,Tyme Initiates Dosing in Pivotal Pancreatic Cancer Study
2020-01-08,"Tyme Out-Licenses Cancer Candidate to Eagle Pharma, Stock Up"
2020-01-08,TYME Announces First Patient Dosed in TYME-88-Panc Pivotal Trial to Evaluate SM-88 as Oral Treatment for Patients with Metastatic Pancreatic Cancer
2020-01-07,Tyme stock rises on Eage collaboration for cancer drug
2020-01-07,Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration to Advance Innovative Oral SM-88 for the Treatment of Patients with Cancer
2019-12-30,Analysts: These 3 Strong Buy Penny Stocks Could Soar in 2020
2019-12-23,"Hedge Funds Have Never Been More Bullish On Tyme Technologies, Inc. (TYME)"
2019-12-12,Wall Street Suggests These Falling Knives
2019-12-04,Tyme Technologies to Present at the 2019 Cross-Border Healthcare Winter Summit in New York
2019-11-25,TYME to Ring Nasdaq Opening Bell on November 27 to Honor All Stakeholders Committed to Finding a Cure for Patients with Pancreatic Cancer
2019-11-21,Tyme Technologies to Present at the Evercore ISI HealthCONx Conference 2019
2019-11-07,"Tyme Technologies to Present at Jefferies 2019 London Healthcare Conference on November 20-21, 2019"
2019-11-04,TYME Presents Business Update and Reports Second Quarter Fiscal 2020 Financial and Operating Results
2019-10-17,TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results
2019-10-17,Lilly's Pancreatic Cancer Candidate Fails in Phase III Study
2019-10-03,"How Much Are Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Taking Off The Table?"
2019-10-01,TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer
2019-09-30,"TYME Presents Supporting Data at ESMO 2019 from TYME-88-Panc Phase II Study Demonstrating Overall Survival Trends, Well Tolerated Safety, and Quality of Life Data in Patients with Advanced Pancreatic Cancer"
2019-09-26,Tyme Initiates Pivotal Stage of Pancreatic Cancer Study
2019-09-25,TYME Launches Pivotal Stage of TYME-88-PANC Trial to Evaluate SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer
2019-09-17,"Tyme Technologies to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019"
2019-09-09,Will Tyme Technologies Continue to Surge Higher?
2019-09-09,TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019
2019-09-04,"Tyme Technologies to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright on September 9, 2019"
2019-08-12,TYME Announces Abstracts Selected for Presentation at the European Society of Medical Oncology Congress 2019
2019-08-09,"Tyme Technologies to Present at BTIG Biotechnology Conference on August 12th, 2019"
2019-08-08,TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
2019-08-07,TYME Announces Abstracts Selected for Presentation at the AACR Special Conference on Pancreatic Cancer
2019-08-01,"Tyme Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference on August 7th, 2019"
2019-07-29,"TYME Technologies Announces New Collaboration with NYU Langone to Advance TYMEs Cancer Metabolism-Based Therapy, SM-88"
2019-07-08,REMINDER - TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
2019-07-05,Tyme Technologies News: Why TYME Stock Is Rocketing
2019-07-05,Tyme Technologies stock soars on heavy volume after upbeat update to cancer treatment study
2019-07-05,TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
2019-06-27,"Will Tyme Technologies, Inc.'s (NASDAQ:TYME) Earnings Grow Over The Next Few Years?"
2019-06-23,Weekly CFO Buys Highlight
2019-06-07,TYME Announces Abstract Selected for Presentation at the European Society for Medical Oncology 21st World Congress on Gastrointestinal Cancer 2019
2019-05-29,TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
2019-05-28,The Tyme Technologies (NASDAQ:TYME) Share Price Is Down 83% So Some Shareholders Are Rather Upset
2019-05-28,"Tyme Technologies to Present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019"
2019-05-24,"Tyme Technologies To Host a Conference Call for the Fourth Quarter and Fiscal Year 2019 Financial and Operating Results on May 29, 2019"
2019-05-23,TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas
2019-05-20,TYME Announces Notification of Issuance of U.S. Patent Covering SM-88 Single Agent Treatment for Cancers
2019-05-09,Tyme Technologies to Participate at the Oppenheimer Oncology Insight Summit on May 16th
2019-05-02,"Tyme Technologies To Present at BioNJ's 9th Annual BioPartnering Conference on May 8th, 2019"
2019-05-01,Tyme Technologies to Participate at the SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on May 7th
2019-04-15,TYME Announces USAN Approval of Generic Name Racemetyrosine for SM-88
2019-04-08,"TYMEs SM-88 First Human Study in Patients with Metastatic Cancer Published in the Journal, Investigational New Drugs"
2019-04-03,TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
2019-04-01,TYME Announces Dismissal of Class Action Lawsuit
2019-03-29,Tyme Technologies Announces Pricing of its $12 Million Registered Offering
2019-03-28,SHAREHOLDER ALERT: VALE TYME UXIN UMC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
2019-03-28,"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tyme Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2019-03-28,"SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tyme Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline  TYME"
2019-03-28,"FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of TYME, GE and AVP"
2019-03-27,"2-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tyme Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2019-03-27,"CLASS ACTION UPDATE for ZIV, TYME and UMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"
2019-03-27,"Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX) - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action"
2019-03-27,"Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tyme Technologies, Inc. (TYME), Vale S.A. (VALE) & Lexicon Pharmaceuticals, Inc. (LXRX)"
